(19)

(11)

EP 4 771 142 A1

(12)

(43) Date of publication: 08.07.2026 Bulletin 2026/28 (21) Application number: 24861125.3 (22) Date of filing: 30.08.2024

(51) International Patent Classification (IPC):  C12N 9/22(2006.01) C12N 15/55(2006.01) C12N 5/10(2006.01) C12P 21/00(2006.01) C12N 15/86(2006.01) (52) Cooperative Patent Classification (CPC): C12N 9/22; C12N 15/86; C12N 2740/13043; C12N 5/0068; C12P 21/02; C07K 16/00; C07K 2317/14; C12Y 301/21001 (86) International application number: PCT/US2024/044635 (87) International publication number: WO 2025/049881 (06.03.2025 Gazette 2025/10)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 01.09.2023 US 202363536279 P (71) Applicant: Catalent Pharma Solutions, LLC Somerset, New Jersey 08873-1213 (US)	(72) Inventor: BLECK, Gregory Somerset, New Jersey 08873-1213 (US) (74) Representative: Algemeen Octrooi- en Merkenbureau B.V.  P.O. Box 645 5600 AP Eindhoven 5600 AP Eindhoven (NL)